Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New HOPE program aims to lift spirits of ovarian cancer patients facing recurrence

NCT ID NCT06666218

First seen Jan 15, 2026 · Last updated Jun 14, 2026 · Updated 18 times

Summary

This study tests a program called HOPE (Helping Ovarian Cancer Patients Cope with Their Disease) to see if it can reduce feelings of hopelessness and helplessness in patients whose ovarian cancer has returned. About 60 adults with recurrent ovarian cancer will either take part in the HOPE workshops or receive usual care. The goal is to improve emotional well-being and quality of life for those facing a difficult prognosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98109, United States

Conditions

The condition(s) this trial relates to.

ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.